Feedback / Questions
inobrodib (CCS1477) - CellCentric
https://www.newsfilecorp.com/release/277119/CellCentric-Presents-Positive-Phase-2-Dose-Optimization-Data-for-Inobrodib-in-Multiple-Myeloma-at-ASH-Annual-Meeting
Dec 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next